Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medivolve Inc MEDVF

Medivolve Inc. is a Canadian healthcare technology company. The Company and its subsidiaries, Medivolve Pharmacy Inc. (doing business as Marbella Pharmacy) and Kedy Ying Jao D.O., a Medical Corporation, operate a distributed network of two retail patient-care locations in California, United States. It has two business units: Medivolve Pharmacy Division (MPD) and Medivolve Clinic Services Division (MCSD). MPD provides retail pharmacy and mail-order pharmacy services related to COVID-19, antibiotics, dermatology, family medicine, immunology, neurology, pain management, pediatrics, preventive medicine and psychiatry to patients in Southern California. MCSD provides licensed healthcare through a clinic in Brea, California, United States. MCSD is focused on developing a telehealth platform, which connects patients with physicians, and facilitates and manages the provision of virtual consultation, diagnosis, and treatment services in partnership with qualified health practitioners.


OTCPK:MEDVF - Post by User

Post by Sarb99on Nov 09, 2020 1:57pm
116 Views
Post# 31864083

Vaccine process must grounded in science fully transparent

Vaccine process must grounded in science fully transparent

Biden: Vaccine process must be "grounded in science and fully transparent"

President-elect Joe Biden said that "we just received positive news in this fight with announcement that there's been progress made toward a successful vaccine" — but added that the process must "be grounded in science and fully transparent."

He continued: "Soon the expectation is the FDA will run the process of rigorous reviews and approvals. And the process must also be grounded in science and fully transparent so the American people can have every confidence that any approved vaccine is safe and effective."

Biden added that even if a vaccine is approved it "will not be widely available for many months yet to come."

His remarks came during a speech from Wilmington, Delaware, after being briefed by his newly formed coronavirus advisory board.

https://www.cnn.com/politics/live-news/election-results-and-news-11-09-20/index.html
<< Previous
Bullboard Posts
Next >>